COLLPLANT BIOTECH. IS-01 Cash Flow Reinvestment Rate

Latest as of December 2021: 12.63x

COLLPLANT BIOTECH. IS-01 cash flow reinvestment rate. COLLPLANT BIOTECH. IS-01 (CPT) has a Cash Flow Reinvestment Rate of 12.63x as of December 2021, reinvesting €31.59 Million (capex €1.59 Million plus investments €-30.00 Million) from operating cash flow of €2.50 Million. Explore COLLPLANT BIOTECH. IS-01 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

12.63x

(Capex + Investments) / Operating CF

Total Reinvested

€31.59 Million

Capex + Investments

Operating Cash Flow

€2.50 Million

EUR

Capital Expenditures

€1.59 Million

EUR

Cash Flow Reinvestment Rate of COLLPLANT BIOTECH. IS-01 (2021–2021)

Cash flow reinvestment rate of COLLPLANT BIOTECH. IS-01 from 2021 to 2021. Historical reinvestment intensity for COLLPLANT BIOTECH. IS-01 across 1 annual periods. Explore how much does COLLPLANT BIOTECH. IS-01 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

COLLPLANT BIOTECH. IS-01 Cash Flow Reinvestment Rate by Year (2021–2021)

COLLPLANT BIOTECH. IS-01 cash flow reinvestment rate by year from 2021 to 2021. Year-by-year capital reinvestment analysis for COLLPLANT BIOTECH. IS-01. For the full cash flow conversion analysis, see CPT cash generation efficiency.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2021	12.63x	€31.59 Million	€2.50 Million	€1.59 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow